跳至主要内容
临床试验/TCTR20131005001
TCTR20131005001进行中(未招募)未知

Immune Response to a Single Simulated Post-Exposure Rabies Booster Vaccination in Six Months after Receiving Incomplete TRC-ID Regimen

Queen Saovabha Memorial Institute0 个研究点目标入组 60 人开始时间: 2013年10月5日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 60 Years(—)
性别
All

入选标准

  • Healthy, age 18-60 years old
  • Willing to participate in this study
  • can follow the protocol study

排除标准

  • - previous history of rabies immunization
  • - immunocompromised conditions
  • - Allergy to rabies vaccine or its components
  • - Pregnant
  • - Receiving blood products within 3 months
  • - Acute illness (Temporary exclusion criteria)

研究者

相似试验

招募中
不适用
CIMAvax-EGF in different maintenance schemeson small cell lung cancerCarcinoma, Non-Small-Cell LungCarcinoma, BronchogenicBronchial NeoplasmsLung NeoplasmsRespiratory Tract NeoplasmsThoracic NeoplasmsLung DiseasesRespiratory Tract DiseasesNSCLC
RPCEC00000368Center of Molecular Immunology (CIM)42
进行中(未招募)
不适用
A Study to Estimate the Immune Response Following a Challenge Dose in Adults (= 50 years old) Vaccinated With a Primary Series of an Hepatitis B VaccineHealthy subjects, active immunisation against Hepatitis BMedDRA version: 12.1Level: LLTClassification code 10019731Term: Hepatitis B
EUCTR2009-016721-33-GBSanofi Pasteur MSD S.N.C296
进行中(未招募)
不适用
A Study to Estimate the Immune Response Following a Challenge Dose in Adults (= 50 years old) Vaccinated With a Primary Series of an Hepatitis B VaccineHealthy subjects, active immunisation against Hepatitis BMedDRA version: 12.1Level: LLTClassification code 10019731Term: Hepatitis B
EUCTR2009-016721-33-SESanofi Pasteur MSD S.N.C296
进行中(未招募)
不适用
A Study to Estimate the Immune Response Following a Challenge Dose in Adults (= 50 years old) Vaccinated With a Primary Series of an Hepatitis B Vaccine
EUCTR2009-016721-33-DKSanofi Pasteur MSD S.N.C296
进行中(未招募)
不适用
Determination of immune response after sequential pneumococcal vaccination using the 7-valent conjugate pneumococcal and the 23-valent pneumococcal polysaccharide vaccine in renal transplant recipients
EUCTR2007-004590-25-ATMedical University of Vienna